Neovacs' Financial Acquisition

Neovacs raised a round of funding on January 01, 2003. Investors include Truffle Capital.

NeoVacs SA is a Paris based vaccine company working on anti-body therapies against human cytokines with a active immunization approach. Its platform is used to develop vaccine products that are induc…

Articles about Neovacs' Financial Acquisition: